74 research outputs found
Positive and negative emotion induction through avatars and its impact on reasoning performance: cardiovascular and pupillary correlates
International audienceMany studies have shown the impact of emotion on cognition (Damasio, 1994), however these influences remain ambiguous. The contradictions may be explained by a lack of experimental control (emotional induction, objective clues on emotional states...) but also by the existence of complex cross-influences between the dorsolateral prefrontal cortex, a major substratum of executive functions (EFs) and the ventromedial prefrontal cortex, an area strongly connected to the limbic system. This work aimed at gaining a more precise view of the links between emotion and EFs, utilizing an experimental protocol that used avatars for a well-controlled emotional induction, measurements of the autonomic nervous system activity as evidence of the emotional state (cardiovascular and pupillary responses) and a neuropsychological test battery (dynamic reasoning and deductive reasoning tasks) for the detection of EFs variations in response to emotion. The experimental data showed that positive emotion (joy) led to a performance decrease during both tasks, together with physiological variations. These counterintuitive results showed that positive mood can impair executive functioning in our tasks. In addition, our results highlighted the lack of learning effects on deductive performance
300 The cardiorenal anaemia syndrome in chronic heart failure: Focus on sympathetic activity
Emotion induction through virtual avatars and its impact on reasoning: evidence from autonomous nervous system measurements and cognitive assessment
Many studies have shown the impact of emotion on cognition (Damasio 1995; Phelps 2004), however these influences remain ambiguous. The contradictions may be explained by a lack of experimental control but also by the existence of complex cross-influences between the dorsolateral prefrontal cortex, a major substratum of the executive functions (EFs) and the ventromedial prefrontal cortex, an area strongly connected to the limbic system (Simpson 2001a). This work aims at gaining a more precise view of the links between emotion and EFs thanks to an experimental protocol that uses Virtual Reality (avatars) for a controlled emotional conditioning, measurements of the autonomous nervous system (ANS) as evidence of the emotional variations and a neuropsychological test battery for the detection of EFs variations, especially reasoning. The batteryâs major tasks consist in deductive reasoning and reasoning in dynamic situations. The experimental data show that positive conditioning leads to a performance decrease (in agreement with Phillips et al. (2002a)), together with physiological variations (cardiac and pupillary activity). Moreover negative conditioning leads to ineffective actions: more actions (Dynamic task), more quickly (Deductive task) with no performance variation. These results may have applications in neuropsychology, for the assessment and the rehabilitation of patients (Mateer et al. 2005) and in neuroergonomics in the field of complex working situations where emotions may cause accidents (e.g. potential source of air crashes, Dehais et al. 2003)
Recommended from our members
Impacts of Microgravity Analogs to Spaceflight on Cerebral Autoregulation.
It is well known that exposure to microgravity in astronauts leads to a plethora physiological responses such as headward fluid shift, body unloading, and cardiovascular deconditioning. When astronauts return to Earth, some encounter problems related to orthostatic intolerance. An impaired cerebral autoregulation (CA), which could be compromised by the effects of microgravity, has been proposed as one of the mechanisms responsible for orthostatic intolerance. CA is a homeostatic mechanism that maintains cerebral blood flow for any variations in cerebral perfusion pressure by adapting the vascular tone and cerebral vessel diameter. The ground-based models of microgravity are useful tools for determining the gravitational impact of spaceflight on human body. The head-down tilt bed rest (HDTBR), where the subject remains in supine position at -6 degrees for periods ranging from few days to several weeks is the most commonly used ground-based model of microgravity for cardiovascular deconditioning. head-down bed rest (HDBR) is able to replicate cephalic fluid shift, immobilization, confinement, and inactivity. Dry immersion (DI) model is another approach where the subject remains immersed in thermoneutral water covered with an elastic waterproof fabric separating the subject from the water. Regarding DI, this analog imitates absence of any supporting structure for the body, centralization of body fluids, immobilization and hypokinesia observed during spaceflight. However, little is known about the impact of microgravity on CA. Here, we review the fundamental principles and the different mechanisms involved in CA. We also consider the different approaches in order to assess CA. Finally, we focus on the effects of short- and long-term spaceflight on CA and compare these findings with two specific analogs to microgravity: HDBR and DI
Clinical autonomic nervous system laboratories in Europe: a joint survey of the European Academy of Neurology and the European Federation of Autonomic Societies
© 2022 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.Background and purpose: Disorders of the autonomic nervous system (ANS) are common conditions, but it is unclear whether access to ANS healthcare provision is homogeneous across European countries. The aim of this study was to identify neurology-driven or interdisciplinary clinical ANS laboratories in Europe, describe their characteristics and explore regional differences.
Methods: We contacted the European national ANS and neurological societies, as well as members of our professional network, to identify clinical ANS laboratories in each country and invite them to answer a web-based survey.
Results: We identified 84 laboratories in 22 countries and 46 (55%) answered the survey. All laboratories perform cardiovascular autonomic function tests, and 83% also perform sweat tests. Testing for catecholamines and autoantibodies are performed in 63% and 56% of laboratories, and epidermal nerve fiber density analysis in 63%. Each laboratory is staffed by a median of two consultants, one resident, one technician and one nurse. The median (interquartile range [IQR]) number of head-up tilt tests/laboratory/year is 105 (49-251). Reflex syncope and neurogenic orthostatic hypotension are the most frequently diagnosed cardiovascular ANS disorders. Thirty-five centers (76%) have an ANS outpatient clinic, with a median (IQR) of 200 (100-360) outpatient visits/year; 42 centers (91%) also offer inpatient care (median 20 [IQR 4-110] inpatient stays/year). Forty-one laboratories (89%) are involved in research activities. We observed a significant difference in the geographical distribution of ANS services among European regions: 11 out of 12 countries from North/West Europe have at least one ANS laboratory versus 11 out of 21 from South/East/Greater Europe (p = 0.021).
Conclusions: This survey highlights disparities in the availability of healthcare services for people with ANS disorders across European countries, stressing the need for improved access to specialized care in South, East and Greater Europe.info:eu-repo/semantics/publishedVersio
EFAS/EAN survey on the influence of the COVID-19 pandemic on European clinical autonomic education and research
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.Purpose: To understand the influence of the coronavirus disease 2019 (COVID-19) pandemic on clinical autonomic education and research in Europe.
Methods: We invited 84 European autonomic centers to complete an online survey, recorded the pre-pandemic-to-pandemic percentage of junior participants in the annual congresses of the European Federation of Autonomic Societies (EFAS) and European Academy of Neurology (EAN) and the pre-pandemic-to-pandemic number of PubMed publications on neurological disorders.
Results: Forty-six centers answered the survey (55%). Twenty-nine centers were involved in clinical autonomic education and experienced pandemic-related didactic interruptions for 9 (5; 9) months. Ninety percent (n = 26/29) of autonomic educational centers reported a negative impact of the COVID-19 pandemic on education quality, and 93% (n = 27/29) established e-learning models. Both the 2020 joint EAN-EFAS virtual congress and the 2021 (virtual) and 2022 (hybrid) EFAS and EAN congresses marked higher percentages of junior participants than in 2019. Forty-one respondents (89%) were autonomic researchers, and 29 of them reported pandemic-related trial interruptions for 5 (2; 9) months. Since the pandemic begin, almost half of the respondents had less time for scientific writing. Likewise, the number of PubMed publications on autonomic topics showed the smallest increase compared with other neurological fields in 2020-2021 and the highest drop in 2022. Autonomic research centers that amended their trial protocols for telemedicine (38%, n = 16/41) maintained higher clinical caseloads during the first pandemic year.
Conclusions: The COVID-19 pandemic had a substantial negative impact on European clinical autonomic education and research. At the same time, it promoted digitalization, favoring more equitable access to autonomic education and improved trial design.info:eu-repo/semantics/publishedVersio
CONSEQUENCES D'UNE OBESITE NUTRITIONNELLE SUR LES FONCTIONS CARDIOVASCULAIRES ET NEUROVEGETATIVES CHEZ LE CHIEN (APPROCHES PHYSIOLOGIQUES ET PHARMACOLOGIQUES (DOCTORAT : PHARMACOLOGIE))
LE KREMLIN-B.- PARIS 11-BU MĂ©d (940432101) / SudocPARIS-BIUM (751062103) / SudocPARIS-BIUP (751062107) / SudocSudocFranceF
Dopamine beta-hydroxylase deficiency.
Dopamine beta-hydroxylase (DbetaH) deficiency is a very rare form of primary autonomic failure characterized by a complete absence of noradrenaline and adrenaline in plasma together with increased dopamine plasma levels. The prevalence of DbetaH deficiency is unknown. Only a limited number of cases with this disease have been reported. DbetaH deficiency is mainly characterized by cardiovascular disorders and severe orthostatic hypotension. First symptoms often start during a complicated perinatal period with hypotension, muscle hypotonia, hypothermia and hypoglycemia. Children with DbetaH deficiency exhibit reduced ability to exercise because of blood pressure inadaptation with exertion and syncope. Symptoms usually worsen progressively during late adolescence and early adulthood with severe orthostatic hypotension, eyelid ptosis, nasal stuffiness and sexual disorders. Limitation in standing tolerance, limited ability to exercise and traumatic morbidity related to falls and syncope may represent later evolution. The syndrome is caused by heterogeneous molecular alterations of the DBH gene and is inherited in an autosomal recessive manner. Restoration of plasma noradrenaline to the normal range can be achieved by therapy with the synthetic precursor of noradrenaline, L-threo-dihydroxyphenylserine (DOPS). Oral administration of 100 to 500 mg DOPS, twice or three times daily, increases blood pressure and reverses the orthostatic intolerance
Conséquences des altérations induites et spontanées du systÚme nerveux autonome sur la fonction cardiovasculaire (approches physiologiques et pharmacologiques)
TOULOUSE3-BU Sciences (315552104) / SudocSudocFranceF
Influence de l'insuline sur la régulation de l'expression du récepteur muscarinique cardiaque dans un modÚle de culture primaire de cardiomyocytes auriculaires
TOULOUSE3-BU Santé-Centrale (315552105) / SudocTOULOUSE3-BU Santé-Allées (315552109) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF
- âŠ